68 Ga-NOTA-functionalized ubiquicidin: Cytotoxicity, biodistribution, radiation dosimetry, and first-in-human PET/CT imaging of infections
Journal of Nuclear Medicine, Volume 59, No. 2, Year 2018
Notification
URL copied to clipboard!
Ubiquicidin is an antimicrobial peptide with great potential for nuclear imaging of infectious diseases, as its cationic-rich fragment TGRAKRRMQYNRR (UBI) has been functionalized with NOTA to allow complexation to 68 Ga ( 68 Ga-NOTA-UBI). We herein assess the cytotoxicity and radiation dosimetry for 68 Ga-NOTA-UBI and a first-in-human evaluation to diagnose infectious processes. Methods: Cytotoxicity was evaluated in green monkey kidney epithelial (Vero) cells and MT-4 leukocytes. Tracer susceptibility was studied in vitro using different bacterial and fungal strains. PET/CT-based biodistribution, pharmacokinetics, and radiation dosimetry were performed on nonhuman primates. Two healthy volunteers and 3 patients with suspected infection underwent 68 Ga-NOTA-UBI PET/CT imaging. Results: Negligible cytotoxicity was determined for NOTA-UBI. 68 Ga-NOTA-UBI showed moderate blood clearance (29-min half-life) and predominant renal clearance in nonhuman primates. Human radiation dose estimates indicated the bladder wall as the dose-critical tissue (185 mSv/MBq), followed by the kidneys (23 mSv/MBq). The total absorbed body dose was low (,7 mSv/MBq); the effective dose was estimated at 17 mSv/MBq. 68 Ga-NOTA-UBI could diagnose bone- and soft-tissue infection in 3 of 3 patients. Conclusion: 68 Ga-NOTA-UBI is considered a nontoxic, safe-to-administer radiopharmaceutical unlikely to cause adverse effects in humans. The favorable tracer biodistribution and the first-in-human results will make 68 Ga-NOTA-UBI PET/CT an encouraging future diagnostic technique with auxiliary clinical relevance.